129 related articles for article (PubMed ID: 23148609)
1. Novel Wnt signaling and other pathway inhibitors in the colorectal cancer genomic landscape era.
Roukos DH; Ziogas DE; Papaloukas C; Baltogiannis G
Future Oncol; 2012 Nov; 8(11):1373-6. PubMed ID: 23148609
[No Abstract] [Full Text] [Related]
2. Drugging the Wnt pathway: problems and progress.
Garber K
J Natl Cancer Inst; 2009 Apr; 101(8):548-50. PubMed ID: 19351922
[No Abstract] [Full Text] [Related]
3. On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling.
McDonald SL; Silver AR
Colorectal Dis; 2011 Apr; 13(4):360-9. PubMed ID: 20015264
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.
Bahrami A; Amerizadeh F; ShahidSales S; Khazaei M; Ghayour-Mobarhan M; Sadeghnia HR; Maftouh M; Hassanian SM; Avan A
J Cell Biochem; 2017 Aug; 118(8):1979-1983. PubMed ID: 28109136
[TBL] [Abstract][Full Text] [Related]
5. Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.
Song S; Christova T; Perusini S; Alizadeh S; Bao RY; Miller BW; Hurren R; Jitkova Y; Gronda M; Isaac M; Joseph B; Subramaniam R; Aman A; Chau A; Hogge DE; Weir SJ; Kasper J; Schimmer AD; Al-awar R; Wrana JL; Attisano L
Cancer Res; 2011 Dec; 71(24):7628-39. PubMed ID: 22009536
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory mechanisms of two Uncaria tomentosa extracts affecting the Wnt-signaling pathway.
Gurrola-Díaz CM; García-López PM; Gulewicz K; Pilarski R; Dihlmann S
Phytomedicine; 2011 Jun; 18(8-9):683-90. PubMed ID: 21156346
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potency of Wnt signaling antagonists in the pathogenesis of prostate cancer, current status and perspectives.
Pashirzad M; Shafiee M; Khazaei M; Fiuji H; Ryzhikov M; Soleimanpour S; Hesari A; Avan A; Hassanian SM
J Cell Physiol; 2019 Feb; 234(2):1237-1247. PubMed ID: 30191954
[TBL] [Abstract][Full Text] [Related]
8. Drug development: Mix and match.
Scudellari M
Nature; 2015 May; 521(7551):S12-4. PubMed ID: 25970452
[No Abstract] [Full Text] [Related]
9. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
[TBL] [Abstract][Full Text] [Related]
10. Study uncovers mutation involved in two cancers.
Cancer Discov; 2015 Jan; 5(1):5-6. PubMed ID: 25583782
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Wnt/frizzled signaling pathway after myocardial infarction: a new tool in the therapeutic toolbox?
Daskalopoulos EP; Hermans KC; Janssen BJ; Matthijs Blankesteijn W
Trends Cardiovasc Med; 2013 May; 23(4):121-7. PubMed ID: 23266229
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling as a therapeutic target for cancer.
Herbst A; Kolligs FT
Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707
[TBL] [Abstract][Full Text] [Related]
13. Targeting Tankyrase to Fight WNT-dependent Tumours.
Thorvaldsen TE
Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):81-88. PubMed ID: 28371398
[TBL] [Abstract][Full Text] [Related]
14. Wnt signaling inside the nucleus.
Shitashige M; Hirohashi S; Yamada T
Cancer Sci; 2008 Apr; 99(4):631-7. PubMed ID: 18177486
[TBL] [Abstract][Full Text] [Related]
15. Targeting the interaction of Aurora kinases and SIRT1 mediated by Wnt signaling pathway in colorectal cancer: A critical review.
Subramaniyan B; Jagadeesan K; Ramakrishnan S; Mathan G
Biomed Pharmacother; 2016 Aug; 82():413-24. PubMed ID: 27470380
[TBL] [Abstract][Full Text] [Related]
16. Effect of Wnt inhibitors in pancreatic cancer.
Wall I; Schmidt-Wolf IG
Anticancer Res; 2014 Oct; 34(10):5375-80. PubMed ID: 25275031
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.
Suzuki H; Watkins DN; Jair KW; Schuebel KE; Markowitz SD; Chen WD; Pretlow TP; Yang B; Akiyama Y; Van Engeland M; Toyota M; Tokino T; Hinoda Y; Imai K; Herman JG; Baylin SB
Nat Genet; 2004 Apr; 36(4):417-22. PubMed ID: 15034581
[TBL] [Abstract][Full Text] [Related]
18. Mining the Wnt pathway for cancer therapeutics.
Barker N; Clevers H
Nat Rev Drug Discov; 2006 Dec; 5(12):997-1014. PubMed ID: 17139285
[TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma.
Ewing GP; Goff LW
Clin Colorectal Cancer; 2010 Oct; 9(4):219-23. PubMed ID: 20920993
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
